BiotechTube
Home/Investors/National Cancer Institute (NCI)

National Cancer Institute (NCI)

Biotech Investor · 8 portfolio companies

Portfolio
8
Focus Areas
7
Top Stage
Pre-clinical

Investment Focus

OncologyHepatologyCardiovascularAutoimmune DiseasesInfectious DiseasesInfectious DiseaseImmunology

Portfolio Companies

CompanyValuation
JBS Science—
Leukogene Therapeutics—
Proteovista—
Intezyne—
AVM Biotechnology—
Kovina Therapeutics—
Flexomics—
Privo Technologies—

Frequent Co-Investors

National Institutes of Health (NIH)3 sharedNational Human Genome Research Institute (NHGRI)2 sharedNational Institute of Dental and Craniofacial Research (NIDCR)2 sharedSCRA SC Launch1 sharedVenture Capital Firms1 sharedNIH1 sharedNational Institute of Allergy and Infectious Diseases (NIAID)1 sharedFDA (via grants/contracts)1 shared